Literature DB >> 11862510

Follow-up of extended pterional orbital decompression in severe Graves' ophthalmopathy.

Marcus C Korinth1, A Ince, W Banghard, J M Gilsbach.   

Abstract

BACKGROUND: Compressive optic neuropathy (CON) with visual loss is, apart from corneal exposure and disfigurating proptosis, the most serious clinical sign encountered in Graves' ophthalmopathy. However, numerous different approaches and operative techniques have been proposed for orbital decompression, with varying results and side effects. The purpose of the present study was to analyze peri-operative data and long-term results in patients with severe thyroid-related orbitopathy, treated by extended pterional orbital decompression, comparing its effectiveness to other procedures.
METHOD: An extended pterional orbital decompression was performed in 42 consecutive patients (59 orbits) with severe thyroid-associated ophthalmopathy after failure of medical and radiation therapy during an 11-year period. Pre- and postoperative examination included visual acuity, Hertel exophthalmometry, ocular motility, visual fields (Goldmann perimetry) and notification of complications. Long-term evaluation was carried out on average at 11 months postoperatively (range 5-26 months).
FINDINGS: Visual acuity improved rapidly from a preoperative average of 0.53 +/- 0.33 (range, 0-1) to 0.77 +/- 0.31 (range, 0-1) postoperatively (p<0.001). Worsening was not seen. An average reduction of proptosis of 3.79 +/- 2.32 mm (range, 0.5-8 mm) was achieved with a mean preoperative Hertel measurement of 24.7 +/- 3.93 mm (range, 15-33 mm) (p<0.001). Double vision and restriction of eye motility was present in 76.3% of patients preoperatively and improved in 63% of patients (p<0.001). No new onsets of not already pre-existing double vision was seen. Complications included two cases of permanent palsy of the frontal branch of the facial nerve.
INTERPRETATION: The extended pterional orbital decompression improved vision and decreased proptosis and restriction of extra-ocular movements in patients with severe sight-threatening and disfiguring cases of Graves' orbitopathy and is still an effective and low-risk alternative to other non-neurosurgical operative techniques. Especially new developing postdecompression strabismus can be successfully avoided.

Entities:  

Mesh:

Year:  2002        PMID: 11862510     DOI: 10.1007/s007010200013

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

1.  [Surgical therapy in Graves' orbitopathy].

Authors:  J Kaminsky; G J Ridder; A Eckstein; M Metzger; F Beisse
Journal:  Ophthalmologe       Date:  2011-05       Impact factor: 1.059

2.  Factors Predicting the Success of Combined Orbital Decompression and Strabismus Surgery in Thyroid-Associated Orbitopathy.

Authors:  Meng-Wei Hsieh; Chih-Kang Hsu; Pao-Cheng Kuo; Hsu-Chieh Chang; Yi-Hao Chen; Ke-Hung Chien
Journal:  J Pers Med       Date:  2022-01-31

3.  [Lateral orbital decompression for Graves' orbitopathy. Indication, surgical technique, and treatment success].

Authors:  N Fichter; M P Schittkowski; H P Vick; R F Guthoff
Journal:  Ophthalmologe       Date:  2004-04       Impact factor: 1.059

4.  Myeloid sarcoma: a rare case of an orbital mass mimicking orbital pseudotumor requiring neurosurgical intervention.

Authors:  Christopher Payne; William C Olivero; Bonnie Wang; Seong-Jin Moon; Arash Farahvar; Eric Chen; Huan Wang
Journal:  Case Rep Neurol Med       Date:  2014-11-16

Review 5.  Surgical complications in orbital decompression for Graves' orbitopathy.

Authors:  S Sellari-Franceschini; I Dallan; A Bajraktari; G Fiacchini; M Nardi; R Rocchi; C Marcocci; M Marinò; A P Casani
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-08       Impact factor: 2.124

Review 6.  Strategies in Surgical Decompression for Thyroid Eye Disease.

Authors:  Anny M S Cheng; Yi-Hsuan Wei; Shu-Lang Liao
Journal:  Oxid Med Cell Longev       Date:  2020-09-09       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.